The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice.

Radiation Research
Devorah C GoldmanWilliam H Fleming

Abstract

Bone marrow suppression due to exposure to ionizing radiation is a significant clinical problem associated with radiation therapy as well as with nonmedical radiation exposure. Currently, there are no small molecule agents available that can enhance hematopoietic regeneration after radiation exposure. Here, we report on the effective mitigation of acute hematopoietic radiation syndrome in mice by the synthetic triterpenoid, RTA 408. The administration of a brief course of RTA 408 treatment, beginning 24 h after lethal doses of radiation to bone marrow, significantly increased overall survival. Importantly, treatment with RTA 408 led to the full recovery of steady state hematopoiesis with normalization of the frequency of hematopoietic stem and progenitor cells. Moreover, hematopoietic stem cells from RTA 408-mitigated mice showed lineage-balanced, long-term, multilineage potential in serial transplantation assays, indicative of their normal self-renewal activity. The potency of RTA 408 in mitigating radiation-induced bone marrow suppression makes it an attractive candidate for potential clinical use in treating both therapy-related and unanticipated radiation exposure.

References

Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·P MauchH J Deeg
Sep 26, 2006·The Journal of Biological Chemistry·Rehan AhmadDonald Kufe
Nov 14, 2006·Biochemical and Biophysical Research Communications·Rajesh K ThimmulappaShyam Biswal
Sep 2, 2009·Stem Cell Research·Bei LiWilliam H Fleming
Sep 18, 2009·Blood·Devorah C GoldmanWilliam H Fleming
Dec 22, 2009·Current Molecular Pharmacology·Mang Xiao, Mark H Whitnall
Jul 16, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jeffery J AulettaJohn J Letterio
Nov 22, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Erik AmesWilliam J Murphy
Dec 12, 2012·Antioxidants & Redox Signaling·Donna D Zhang
Oct 16, 2013·Antioxidants & Redox Signaling·Lijian ShaoDaohong Zhou
Jan 28, 2014·The Journal of Clinical Investigation·Jung-Hyun KimShyam Biswal

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
flow cytometry
nuclear translocation

Software Mentioned

FlowJo

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.